Category: isoxazole

Role of Nrf2/HO-1 signaling pathway in treatment of schizophrenia rats with paliperidone was written by Wang, Li;Zhang, Song;Long, Wei. And the article was included in Zhongguo Laonianxue Zazhi in 2022.COA of Formula: C23H27FN4O3 This article mentions the following:

Objective: To investigate the mechanism of NF-E2-related factor (Nrf)2/heme oxygenase (HO)-1 signaling pathway in the treatment of schizophrenia (SZ) rats with paliperidone. Methods: Fifty SPF SD rats were randomly divided into 5 groups: control group (Control group), SZ group (Model group), risperidone group, low-dose paliperidone group and high-dose paliperidone group. The rat model of SZ development was established by i.p. injection of didroxepine maleate (MK-801, 0.25 mg/kg). Rats in low-dose paliperidone group, high-dose paliperidone group and risperidone group were given paliperidone (0.03 mg/kg, once daily), paliperidone (0.30 mg/kg, once daily) and risperidone (0.10), resp. mg/kg, once a day), and rats in Control group and Model group were given the same amount of normal saline. The open field test box was used to analyze the changes of total distance within 10 min in each group. Morris water maze was used to test the reference memory of rats in each group. Social interaction test box was used to test the social interaction ability of rats in each group. And Western blotting was used to detect the expression levels of Caspase-3, Bax protein, Nrf2 and HO-1 in hippocampus tissues of rats in each group. Results: Compared with the Control group, the total distance of spontaneous activity in the Model group was significantly increased, the escape latency was significantly increased, the frequency of crossing the platform was significantly decreased, and the social interaction time and the percentage of non-aggressive behavior were significantly decreased (P<0.05). Compared with the Model group, the total distance of spontaneous activity in risperidone group, the low-dose paliperidone group and the high-dose paliperidone group were significantly decreased, the escape latency was significantly decreased, the number of platform crossing was significantly increased, the social interaction time and the percentage of non-aggressive behavior were significantly increased (P<0.05). Compared with the Control group, the expression levels of caspas-3 and Bax protein in the Model group were significantly increased, and the expression levels of Nrf2 and HO-1 protein were significantly decreased (P<0.05). Compared with the Model group, the protein expression levels of digested caspase-3 and Bax in the hippocampus of risperidone group, low-dose paliperidone group and high-dose paliperidone group were significantly decreased, and the protein expression levels of Nrf2 and HO-1 were significantly increased (P<0.05). Conclusion: Paliperidone can alleviate abnormal behavior in SZ model rats, and may play a role by regulating Nrf2/HO-1 signaling pathway. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4COA of Formula: C23H27FN4O3).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazoles are aromatic heterocycles containing an N–O bond. The weakness of this bond allows the ring opening of these heterocycles under reductive conditions. As with isoxazolines, isoxazoles may be cleaved using low-valent titanium obtained from the Kulinkovich reaction.This procedure affords enaminoketones from 2,4-substituted isoxazoles.COA of Formula: C23H27FN4O3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Quantification of panel of most potent antipsychotic medicines by high throughput UPLC method was written by Jebaliya, Hetal;Shah, Anamik;Karad, Sharad C.;Nakum, Shraddha;Dabhi, Batuk. And the article was included in Results in Chemistry in 2022.COA of Formula: C23H27FN4O3 This article mentions the following:

The delegated work entails the simultaneous quantification and validation of a panel of common antipsychotic compounds in dosage form using the UPLC method. The antipsychotic medications used in the study were; Amisulpride, Risperidone, Paliperidone, Ziprasidone, Aripiprazole and Lurasidone. Acquity UPLC@BEH shield RP C18 (100 mm X 2.1 mm id, 1.7 m particle size) column was used to sep. the samples with gradient elution consisting of 0.1% TFA and ACN with a PDA detector. The entire anal. took only 7 min with a 0.3 mL/min flow rate, 1 μl injection volume and a 45 °C column oven temperature The current approach provides good resolution and low solvent consumption in a short amount of time. In most Quality Control laboratories, time-consuming methods and distinct mobile phases are used for different dosage forms of pharmaceuticals, however, the proposed method saves time and money by removing the need to change mobile phases. As a result, the method can be used in QC laboratories where time-consuming methods are used with different mobile-stationary phases. Antipsychotic drug anal. is mainly utilized in QC laboratory and forensic toxicol. to monitor medication therapy or to explain the cause of intoxication in human performance and post-mortem situations. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4COA of Formula: C23H27FN4O3).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazoles are aromatic heterocycles containing an N–O bond. Isoxazoles are commonly used as enaminoketone or β-diketone surrogate. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.COA of Formula: C23H27FN4O3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample was written by Schoretsanitis, Georgios;Haen, Ekkehard;Conca, Andreas;Piacentino, Daria;Ridders, Florian;Hiemke, Christoph;Grunder, Gerhard;Paulzen, Michael. And the article was included in Pharmacopsychiatry in 2021.Synthetic Route of C23H27FN4O3 This article mentions the following:

IntroductionMajor smoking effects have been reported for a series of psychotropic agents, mainly including substrates of CYP450 1A2, although smoking may also affect alternative metabolic pathways. To our knowledge, smoking effects on paliperidone pharmacokinetics have not been assessed yet. MethodsWe compared plasma concentrations of paliperidone as well as dose-corrected-plasma concentrations (C/D) from a naturalistic database between smokers and nonsmokers using nonparametrical tests, such as the Mann-Whitney U-test (MWU). Addnl., we compared light and heavy smokers with nonsmokers sep. ResultsComparing 55 smokers with 37 nonsmokers treated with oral paliperidone, no differences in the percentage of females, age, body weight, body mass index, and daily paliperidone dose were reported (p=0.709 for χ ², p=0.26, p=0.38, p=0.67, and p=0.8 for MWU). No differences were detected in plasma concentrations or C/D values (p=0.50 and p=0.96 for MWU). Likewise, differences in daily dose, plasma concentrations, or C/D values were not significant between light smokers (n=17) and nonsmokers (p=0.61, p=0.81, and p=0.33 for MWU) or heavy smokers (n=22) and nonsmokers (p=0.874, p=0.38, and p=0.59; MWU in all cases). DiscussionPaliperidone is not affected by smoking, and paliperidone dose-adjustments in smokers may not be necessary. This may be seen as an essential difference to risperidone, whose cytochrome-mediated metabolism might be affected by smoking. In the experiment, the researchers used many compounds, for example, 3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4Synthetic Route of C23H27FN4O3).

3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one (cas: 144598-75-4) belongs to isoxazole derivatives. Isoxazole are described as inhibitors of acetylcholinesterase (AChE). Isoxazole ligands bind to and inhibit the Sxc- antiporter. Some alternative routes for the synthesis of isoxazoles have also been developed and reported. The 2-benzoyl-2-halo-2H-azirines provide 4-haloisoxazoles in good yields after heating in toluene at reflux temperature.Synthetic Route of C23H27FN4O3

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Bromodomain and extra-terminal (BET) inhibitors in treating myeloid neoplasms was written by Chen, Natalie Cheng;Borthakur, Gautam;Pemmaraju, Naveen. And the article was included in Leukemia & Lymphoma in 2021.Application In Synthesis of (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide This article mentions the following:

With improved understanding of the epigenetic alterations underlying cancer development, numerous novel agents targeting pathways involved in epigenetic modifications and transcription including bromodomain inhibitors are under active investigation. We aim to discuss epigenetic modulation with a focus on bromodomain extra-terminal inhibitors (BETi) in the treatment of myeloid neoplasms. Since the first proof-of-concept description of BETi synthesis and its antineoplastic effect, approx. 20 BETi have been generated and many of them are studied in the context of cancer treatment. Emerging pre-clin. and early clin. studies suggest that BETi may have activity in the management of many hematol. malignancies including acute myeloid leukemia (AML), blastic plasmacytoid dendritic cell neoplasm (BPDCN), myeloproliferative neoplasm (MPNs), and lymphoma. We comprehensively reviewed and summarized preclin. and clin. data on BETi in treating myeloid neoplasms. In the experiment, the researchers used many compounds, for example, (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide (cas: 1380087-89-7Application In Synthesis of (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide).

(S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide (cas: 1380087-89-7) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. Some alternative routes for the synthesis of isoxazoles have also been developed and reported. The 2-benzoyl-2-halo-2H-azirines provide 4-haloisoxazoles in good yields after heating in toluene at reflux temperature.Application In Synthesis of (S)-2-(6-(4-Chlorophenyl)-1-methyl-4H-benzo[c]isoxazolo[4,5-e]azepin-4-yl)acetamide

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Reactions of 5-Aminoisoxazoles with α-Diazocarbonyl Compounds: Wolff Rearrangement vs N-H Insertion was written by Ge, Yun;Sun, Wangbin;Chen, Yang;Huang, Yulin;Liu, Zhuang;Jiang, Yaojia;Loh, Teck-Peng. And the article was included in Journal of Organic Chemistry in 2019.Recommanded Product: 59669-59-9 This article mentions the following:

A highly chemoselective reaction between 5-aminoisoxazoles and α-diazocarbonyl compounds has been described. Both Wolff rearrangement and N-H insertion products can be obtained selectively by the judicious choice of reaction conditions. In the case of the Wolff rearrangement reactions, the N-isoxazole amides are accessed as the sole products under thermal conditions. On the other hand, α-amino acid derivatives of N-isoxazoles can be obtained through N-H insertion reactions in the presence of catalytic Rh₂(Oct)₄. Both reactions proceed under mild reaction conditions and feature a broad substrate scope. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Recommanded Product: 59669-59-9).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives.Synthetically, isoxazoles serve as valuable precursors for the construction of diverse molecules, including many natural products. Some alternative routes for the synthesis of isoxazoles have also been developed and reported. The 2-benzoyl-2-halo-2H-azirines provide 4-haloisoxazoles in good yields after heating in toluene at reflux temperature.Recommanded Product: 59669-59-9

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Discovery of a new class of p38 kinase inhibitors was written by Dumas, J.;Sibley, R.;Riedl, B.;Monahan, M. K.;Lee, W.;Lowinger, T. B.;Redman, A. M.;Johnson, J. S.;Kingery-Wood, J.;Scott, W. J.;Smith, R. A.;Bobko, M.;Schoenleber, R.;Ranges, G. E.;Housley, T. J.;Bhargava, A.;Wilhelm, S. M.;Shrikhande, A.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2000.Category: isoxazole This article mentions the following:

The MAP kinase p38 has been implicated in cytokine signaling, and its inhibitors are potentially useful for the treatment of arthritis and osteoporosis. Novel small-mol. inhibitors of p38 kinase were derived from a combinatorial chem. effort and exhibit activity in the nanomolar range. Very steep structure-activity relationships are observed within this class. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Category: isoxazole).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. Isoxazoles are aromatic heterocycles containing an N–O bond. Isoxazoles are commonly used as enaminoketone or β-diketone surrogate. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Category: isoxazole

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

AgNTf₂-catalyzed formal [3+2] cycloaddition of ynamides with unprotected isoxazol-5-amines: efficient access to functionalized 5-amino-1H-pyrrole-3-carboxamide derivatives was written by Cao, Ziping;Zhu, Jiekun;Liu, Li;Pang, Yuanling;Tian, Laijin;Sun, Xuejun;Meng, Xin. And the article was included in Beilstein Journal of Organic Chemistry in 2019.Formula: C7H12N2O This article mentions the following:

A formal [3 + 2] cycloaddition between ynamides RCCN(R¹C₆H₅)R² (R = H, 2-Me, 4-F, 3-Me, etc.; R¹ = Me, Bn, Ph, etc.; R² = Ts, Ms, o-Ns, p-Ns) and unprotected isoxazol-5-amines I (R³ = Me, Ph, i-Pr, etc.) has been developed in the presence of catalytic AgNTf₂ in an open flask. By the protocol, a variety of functionalized 5-amino-1H-pyrrole-3-carboxamide derivatives II can be obtained in up to 99% yield. The reaction mechanism might involve the generation of an unusual alpha-imino silver carbene intermediate (or a silver-stabilized carbocation) and subsequent cyclization/isomerization to build the significant pyrrole-3-carboxamide motif. The reaction features the use of an inexpensive catalyst, simple reaction conditions, simple work-up without column chromatog. purification for most of products and high yields. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Formula: C7H12N2O).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. An isoxazolyl group is found in many beta-lactamase-resistant antibiotics, such as cloxacillin, dicloxacillin and flucloxacillin. Fe(CO)5 efficiently cleaves the N–O bond of fused isoxazolo-1,4-quinones to give the corresponding imines.All the common reducing reagents failed to open the isoxazole ring.Formula: C7H12N2O

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

2-Arylimino-5,6-dihydro-4H-1,3-thiazines as a new class of cannabinoid receptor agonists. Part 3: Synthesis and activity of isosteric analogs was written by Kai, Hiroyuki;Morioka, Yasuhide;Koriyama, Yuji;Okamoto, Kazuya;Hasegawa, Yasushi;Hattori, Maki;Koike, Katsumi;Chiba, Hiroki;Shinohara, Shunji;Iwamoto, Yuka;Takahashi, Kohji;Tanimoto, Norihiko. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2008.Application of 59669-59-9 This article mentions the following:

Structure-activity relationships and efforts to optimize the pharmacokinetic profile of isosteric analogs of 2-arylimino-5,6-dihydro-4H-1,3-thiazines as cannabinoid receptor agonists are described. Among those examined, compound I showed potent affinity for cannabinoid receptor 1 (CB1) and receptor 2 (CB2). This compound displayed oral bioavailability and analgesic activity. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Application of 59669-59-9).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. Isoxazoles also form the basis for a number of drugs, including the COX-2 inhibitor valdecoxib (Bextra) and a neurotransmitter agonist AMPA. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.Application of 59669-59-9

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

In-Silico Screening of Novel Synthesized Thienopyrimidines Targeting Fms Related Receptor Tyrosine Kinase-3 and Their In-Vitro Biological Evaluation was written by Elmongy, Elshaymaa I.;Altwaijry, Najla;Attallah, Nashwah G. M.;AlKahtani, Manal Mubarak;Henidi, Hanan Ali. And the article was included in Pharmaceuticals in 2022.Quality Control of 3-(tert-Butyl)isoxazol-5-amine This article mentions the following:

The present investigation describes the design strategy and synthesis of novel thienopyrimidine compounds in addition to their anticancer activity targeting tyrosine kinase FLT3 enzyme. The synthesized compounds were subjected to a cytotoxic study where compounds I and II showed the most potent cytotoxicity against HT-29, HepG-2, and MCF-7 cell lines reflected by their IC₅₀ values for I (1.21 ± 0.34, 6.62 ± 0.7 and 7.2 ± 1.9μM), for II (0.85 ± 0.16, 9.11 ± 0.3 and 16.26 ± 2.3μM) and better than that of reference standard which recorded (1.4 ± 1.16, 13.915 ± 2.2, and 8.43 ± 0.5μM), resp. Compounds’ selectivity to malignant cells was determined using selectivity assay, interestingly, all the tested compounds demonstrated an excellent selectivity index (SI) range from 20.2 to 99.7. Mol. docking studies were performed on the prepared compounds which showed promising binding affinity for FLT3 kinase enzyme and the main interactions between the synthesized ligands and kinase active site were similar to those between the co-crystallized ligand and the receptor. Further biol. exploration was performed using in-vitro FLT3 kinase enzyme inhibition assay. The results showed that the 2-morpholinoacetamido derivative exhibited highest FLT3 inhibitory activity among the tested compounds followed by compound I then compound III. Pharmacokinetic assessment disclosed that all the investigated compounds were considered as “drug-like” mols. with promising bioavailability. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Quality Control of 3-(tert-Butyl)isoxazol-5-amine).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. The most common methods for N–O bond cleavage in isoxazoles are hydrogenation with palladium or platinum catalysts or with Raney Ni. Recent developments have shown that Mo(CO)6 efficiently cleaves the N–O bond in isoxazoles.Quality Control of 3-(tert-Butyl)isoxazol-5-amine

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem

Hoveyda-Grubbs II Catalyst: A Useful Catalyst for One-Pot Visible-Light-Promoted Ring Contraction and Olefin Metathesis Reactions was written by Ge, Yun;Sun, Wangbin;Pei, Bingbing;Ding, Jia;Jiang, Yaojia;Loh, Teck-Peng. And the article was included in Organic Letters in 2018.HPLC of Formula: 59669-59-9 This article mentions the following:

A one-pot reaction to synthesize functionalized 2H-azirines through visible-light-mediated ring contraction and olefin metathesis of isoxazoles is described. Hoveyda-Grubbs II catalyst was found to function as a photocatalyst for these transformations, allowing these processes to be carried out in a one-pot manner. This study offers a new entry for the application of Grubbs catalysts as efficient photocatalysts and the possibilities of carrying out other photoreactions and olefin metathesis in a one-pot process. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9HPLC of Formula: 59669-59-9).

3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. Isoxazoles also form the basis for a number of drugs, including the COX-2 inhibitor valdecoxib (Bextra) and a neurotransmitter agonist AMPA. Isoxazoles are potent isosteres of pyridine and have been found to inhibit voltage-gated sodium channels for pain control, for the construction of tetracycline antibiotic derivatives, and as a therapeutic agent for depression.HPLC of Formula: 59669-59-9

Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem